Congress Materials

Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

I am a U.S. Healthcare ProfessionalYes, I am a U.S. Healthcare Professional
SelectI am a U.S. Healthcare ProfessionalYes, I am a U.S. Healthcare Professional
I am a U.S. Patient / CaregiverNo, go back to the patient portal
SelectI am a U.S. Patient / CaregiverNo, go back to the patient portal
Non-US residents click here.

Congress Materials

The information on this page pertains to select congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Congress materials may include information for which the product is not approved and/or inconsistent with the product uses described in the Prescribing Information. Pfizer does not suggest or recommend the use of Pfizer Products in any manner other than as described in the Prescribing Information.
Poster
Spratt DE, McKay RR, Dorff T, Lowentritt B, Fallick M, Hanson S, Ross A February 16, 2023 ASCO GU 2023 Oncology

A Multi-Center, Prospective, Observational Study of Prostate Cancer Patients Being Treated With Relugolix: OPTYX

View Presentation View Abstract Plain Language Summary
Poster
Morgans AK, Ebrahimi R, Bobbili P, Nwokeji E, Gandhi R, Desai R, Horvath K, Ryan M, Hanson S, Duh MS, Preston MA February 16, 2023 ASCO GU 2023 Oncology

Association of Intermittent Versus Continuous Androgen Deprivation Therapy With Cardiovascular Disease and Endocrine/Metabolic Disorders in Patients With Metastatic Prostate Cancer

View Presentation
Poster
Morgans AK, Ebrahimi R, Bobbili P, Nwokeji E, Gandhi R, Desai R, Zhang A, Ryan M, Hanson S, Duh MS, Preston MA February 16, 2023 ASCO GU 2023 Oncology

Association of Intermittent Versus Continuous Androgen Deprivation Therapy With Cardiovascular Disease and Endocrine/Metabolic Disorders in Patients With Nonmetastatic Prostate Cancer

View Presentation
Poster
Collins SP, Maculaitis MC, Hauber B, Hunsche E, Kopenhafer L, Nwokeji E, Beusterien KM February 16, 2023 ASCO GU 2023 Oncology

Identifying Prostate Cancer Patient Subgroups Based on Their Preferences for Key Attributes of Androgen Deprivation Therapies

View Presentation View Abstract Plain Language Summary
Poster
DerSarkissian M, Gupta D, Ivanova J, Niyazov A, Arondekar B, Zanardo E, Guo T, Wang J, Duh MS, Freedland SJ February 16, 2023 ASCO GU 2023 Oncology

Racial Differences in Survival and Healthcare Resource Utilization Among Medicaid-insured Adults With Metastatic Castration-Resistant Prostate Cancer

View Presentation View Abstract Plain Language Summary
Poster
DerSarkissian M, Gupta D, Ivanova J, Niyazov A, Arondekar B, Zanardo E, Guo T, Wang J, Duh MS, Freedland SJ February 16, 2023 ASCO GU 2023 Oncology

Racial Differences in Survival and Healthcare Resource Utilization Among Medicaid-insured Adults With Metastatic Castration-Sensitive Prostate Cancer

View Presentation View Abstract Plain Language Summary
Poster
McKay RR, Gandhi R, Yang E, Pruett J, Nwokeji E, Fallick M February 16, 2023 ASCO GU 2023 Oncology

Real-World Combination Therapy Patterns in Patients Receiving Leuprolide or Relugolix for Androgen Deprivation Therapy in 2021 (The REAL-ADT COMBO Study): Analysis from a US EMR Database

View Presentation View Abstract Plain Language Summary
Poster
Barata P, Assayag J, Li B, Siu G, Nazari J, Niyazov A February 16, 2023 ASCO GU 2023 Oncology

Real-World Homologous Recombination Repair Gene Mutation Testing Trends in Patients With Metastatic Castration-Resistant Prostate Cancer in the United States

View Presentation View Abstract Plain Language Summary
Poster
Barata P, Montgomery R, Gillespie-Akar L, Nazari J, Arondekar B, Niyazov A February 16, 2023 ASCO GU 2023 Oncology

Real-World Homologous Recombination Repair Mutation Testing Patterns in Patients With Metastatic Castration-Sensitive Prostate Cancer in the US

View Presentation View Abstract Plain Language Summary
Poster
Swami U, Xie B, Young C, Ramaswamy K, El-Chaar N, Gao W, Yang H, Wang Y, Mucha L February 16, 2023 ASCO GU 2023 Oncology

Real-World Prevalence of Adverse Events Among Patients With Metastatic Castration-Sensitive Prostate Cancer

View Presentation View Abstract Plain Language Summary